benzbromarone has been researched along with Deafness in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oudot, J | 1 |
| Martin, H | 1 |
1 other study available for benzbromarone and Deafness
| Article | Year |
|---|---|
[Possible effect of Désuric on reported deafness in hyperuremic patients. Apropos of 30 cases].
Topics: Aged; Benzbromarone; Benzofurans; Deafness; Female; Humans; Male; Middle Aged; Uremia | 1979 |